Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onradivir in Adults with Acute Uncomplicated Influenza A
NCT04024137Phase 2Completed
- Sponsor
- Raynovent Biotech
- Start
- Dec 2019
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of anlatrelvir in Influenza A (IAV), sponsored by Raynovent Biotech. Started Dec 2019; status: completed.
02
Drugs
anlatrelvir
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT04024137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04024137.